Human Milk Oligosaccharides (HMO) Market Report

Europe Human Milk Oligosaccharides (HMO) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 20, 2020
  • PAGES：159
  • REPORT CODE：GMM564065
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces.Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.

    The Human Milk Oligosaccharides (HMO) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Milk Oligosaccharides (HMO) Market Segmentations:

    By Player:

    • Jennewein Biotechnologie

    • Dextra Laboratories

    • Inbiose

    • Elicityl SA

    • ZuChem

    • Glycom

    By Type:

    • Neutral

    • Acidic

    • Other

    By End-User:

    • Infant formula

    • Functional food & beverages

    • Food supplements

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Milk Oligosaccharides (HMO) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral from 2014 to 2026

    • 1.3.2 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic from 2014 to 2026

    • 1.3.3 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Infant formula from 2014 to 2026

    • 1.4.2 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Functional food & beverages from 2014 to 2026

    • 1.4.3 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Food supplements from 2014 to 2026

    • 1.4.4 Europe Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Milk Oligosaccharides (HMO) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Milk Oligosaccharides (HMO) by Major Types

      • 3.4.1 Market Size and Growth Rate of Neutral

      • 3.4.2 Market Size and Growth Rate of Acidic

      • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Human Milk Oligosaccharides (HMO) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Milk Oligosaccharides (HMO) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Infant formula for Construction

      • 4.4.2 Market Size and Growth Rate of Functional food & beverages for Construction

      • 4.4.3 Market Size and Growth Rate of Food supplements for Construction

      • 4.4.4 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Milk Oligosaccharides (HMO) Production Analysis by Top Regions

    • 5.2 Europe Human Milk Oligosaccharides (HMO) Consumption Analysis by Top Regions

    • 5.3 Europe Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Milk Oligosaccharides (HMO) Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 7.1 Germany Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 7.2 Germany Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    8. UK Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 8.1 UK Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 8.2 UK Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    9. France Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 9.1 France Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 9.2 France Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    10. Italy Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 10.1 Italy Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 10.2 Italy Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    11. Spain Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 11.1 Spain Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 11.2 Spain Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    12. Poland Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 12.1 Poland Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 12.2 Poland Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    13. Russia Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 13.1 Russia Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 13.2 Russia Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    14. Switzerland Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 14.1 Switzerland Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 14.2 Switzerland Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    15. Turkey Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 15.1 Turkey Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 15.2 Turkey Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 16.3.2 Finland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 16.3.3 Norway Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 16.3.4 Sweden Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 16.3.6 Iceland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 18.3.2 Latvia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Jennewein Biotechnologie

      • 19.1.1 Jennewein Biotechnologie Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Dextra Laboratories

      • 19.2.1 Dextra Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Inbiose

      • 19.3.1 Inbiose Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Elicityl SA

      • 19.4.1 Elicityl SA Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 ZuChem

      • 19.5.1 ZuChem Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Glycom

      • 19.6.1 Glycom Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 113 Figures and 169 Tables)

    • Figure Product Picture

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral Market, 2015 - 2026 (USD Million)

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic Market, 2015 - 2026 (USD Million)

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other Market, 2015 - 2026 (USD Million)

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Infant formula from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Functional food & beverages from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Food supplements from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Milk Oligosaccharides (HMO) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Milk Oligosaccharides (HMO) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Milk Oligosaccharides (HMO)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Milk Oligosaccharides (HMO) by Different Types from 2014 to 2026

    • Table Consumption Share of Human Milk Oligosaccharides (HMO) by Different Types from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Neutral Market, 2015 - 2026 (USD Million)

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Acidic Market, 2015 - 2026 (USD Million)

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Other Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Milk Oligosaccharides (HMO) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Milk Oligosaccharides (HMO) by Different End-Users from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Infant formula from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Functional food & beverages from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Food supplements from 2014 to 2026

    • Figure Human Milk Oligosaccharides (HMO) Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Human Milk Oligosaccharides (HMO) Production by Major Regions

    • Table Europe Human Milk Oligosaccharides (HMO) Production Share by Major Regions

    • Figure Europe Human Milk Oligosaccharides (HMO) Production Share by Major Countries and Regions in 2014

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption by Major Regions

    • Table Europe Human Milk Oligosaccharides (HMO) Consumption Share by Major Regions

    • Table Germany Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table UK Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table France Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Italy Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Spain Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Poland Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Russia Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Turkey Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Milk Oligosaccharides (HMO) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Germany Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Germany Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Germany Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table UK Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table UK Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table UK Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table France Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table France Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table France Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table France Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Italy Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Italy Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Italy Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Spain Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Spain Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Spain Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Poland Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Poland Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Poland Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Russia Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Russia Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Russia Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Switzerland Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Turkey Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Milk Oligosaccharides (HMO) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Milk Oligosaccharides (HMO) Market Volume and Growth Rate from 2014 to 2026

    • Table Jennewein Biotechnologie Profiles

    • Table Jennewein Biotechnologie Production, Value, Price, Gross Margin 2014-2019

    • Table Jennewein Biotechnologie Product benchmarking

    • Table Jennewein Biotechnologie Strategic initiatives

    • Table Jennewein Biotechnologie SWOT analysis

    • Table Dextra Laboratories Profiles

    • Table Dextra Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Dextra Laboratories Product benchmarking

    • Table Dextra Laboratories Strategic initiatives

    • Table Dextra Laboratories SWOT analysis

    • Table Inbiose Profiles

    • Table Inbiose Production, Value, Price, Gross Margin 2014-2019

    • Table Inbiose Product benchmarking

    • Table Inbiose Strategic initiatives

    • Table Inbiose SWOT analysis

    • Table Elicityl SA Profiles

    • Table Elicityl SA Production, Value, Price, Gross Margin 2014-2019

    • Table Elicityl SA Product benchmarking

    • Table Elicityl SA Strategic initiatives

    • Table Elicityl SA SWOT analysis

    • Table ZuChem Profiles

    • Table ZuChem Production, Value, Price, Gross Margin 2014-2019

    • Table ZuChem Product benchmarking

    • Table ZuChem Strategic initiatives

    • Table ZuChem SWOT analysis

    • Table Glycom Profiles

    • Table Glycom Production, Value, Price, Gross Margin 2014-2019

    • Table Glycom Product benchmarking

    • Table Glycom Strategic initiatives

    • Table Glycom SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US